Alyacen 1/35 NDC 71205-547

NDC codes

FDA NDC Directory

Product NDC (as listed)71205-547Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71205-0547Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71205-547-28	71205054728	1 PACKAGE in 1 BAG (71205-547-28) / 1 KIT in 1 PACKAGEMarketed from Mar 25, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Alyacen 1/35
Generic name (nonproprietary): norethindrone and ethinyl estradiol
Dosage form: Kit
Labeler: Proficient Rx LP
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091634
Marketing start: Jan 19, 2012
Listing expires: Dec 31, 2027
Identifiers: Product ID 71205-547_660c806f-2e79-4234-a83c-80224454e964SPL ID 660c806f-2e79-4234-a83c-80224454e964SPL set ID fa32e05b-c86d-4743-aee5-be3fc515152bRxCUI 312033, 748797, 749858, 1242786UPC 0371205547288

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N471205054728 followed by a unit qualifier and the quantity

Package 71205-0547-28. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 1, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE ALYACEN 1/35 Tabletsare indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. Oral contraceptives are highly effective. Table 1 lists the typical accidental pregnancy rates for users of combined oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization, the IUD, and the NORPLANT ® System depends upon the reliability with which they are used. Correct and consistent use of methods can result in lower failure rates. Table 1: Percentage of Women Experiencing an Unintended Pregnancy During the First Year of Typical Use and the First Year of Perfect Use of …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 091634

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091634
Product	Strength	Form · route	Labeler	Product NDC
Alyacen 1/35norethindrone and ethinyl estradiol	—	Kit	A-S Medication Solutions	50090-1477
Alyacen 1/35norethindrone and ethinyl estradiol	—	Kit	Glenmark Pharmaceuticals Inc., USA	68462-394